{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=prochlorperazine&page=2", "query": { "intervention": "prochlorperazine", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=prochlorperazine&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-22T12:18:26.787Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05768919", "title": "Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Glioblastoma" ], "interventions": [ { "name": "Treatment Period 1", "type": "DRUG" }, { "name": "Treatment Period 2", "type": "DRUG" }, { "name": "Treatment Period 3", "type": "DRUG" }, { "name": "Treatment Period 4a", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SignPath Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2023-03-03", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2024-11-29", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Baltimore, Maryland", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05768919" }, { "nct_id": "NCT05967442", "title": "Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine", "Headache" ], "interventions": [ { "name": "Magnesium Sulfate", "type": "DRUG" }, { "name": "Metoclopramide 10mg", "type": "DRUG" }, { "name": "Prochlorperazine (Compazine) Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 157, "start_date": "2019-08-23", "completion_date": "2023-04-06", "has_results": true, "last_update_posted_date": "2024-10-08", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 1, "location_summary": "Oak Lawn, Illinois", "locations": [ { "city": "Oak Lawn", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05967442" }, { "nct_id": "NCT06182098", "title": "Intravenous Fluids in Pediatric Migraine", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Migraine", "Migraine in Children" ], "interventions": [ { "name": "1/2 maintenance fluids", "type": "OTHER" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Prochlorperazine", "type": "DRUG" }, { "name": "bolus", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Dayton Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "5 Years to 21 Years" }, "enrollment_count": 134, "start_date": "2023-06-27", "completion_date": "2025-06", "has_results": false, "last_update_posted_date": "2023-12-26", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 1, "location_summary": "Dayton, Ohio", "locations": [ { "city": "Dayton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06182098" }, { "nct_id": "NCT06450899", "title": "Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Mountain Sickness" ], "interventions": [ { "name": "Prochlorperazine Maleate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 57, "start_date": "2024-08-05", "completion_date": "2024-08-28", "has_results": false, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 1, "location_summary": "Evergreen, Colorado", "locations": [ { "city": "Evergreen", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06450899" }, { "nct_id": "NCT02858310", "title": "E7 TCR T Cells for Human Papillomavirus-Associated Cancers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Papillomavirus Infections", "Cervical Intraepithelial Neoplasia", "Carcinoma In Situ", "Vulvar Neoplasms", "Vulvar Diseases" ], "interventions": [ { "name": "E7 TCR cells", "type": "BIOLOGICAL" }, { "name": "Aldesleukin", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "EKG", "type": "DIAGNOSTIC_TEST" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Chest CT and MRI or PET", "type": "DIAGNOSTIC_TEST" }, { "name": "PFT", "type": "DIAGNOSTIC_TEST" }, { "name": "Granisetron", "type": "DRUG" }, { "name": "Ondansetron", "type": "DRUG" }, { "name": "Droperidol", "type": "DRUG" }, { "name": "Prochlorperazine", "type": "DRUG" }, { "name": "Diphenoxylate HCL", "type": "DRUG" }, { "name": "Atropine sulfate", "type": "DRUG" }, { "name": "Codeine sulfate", "type": "DRUG" }, { "name": "Loperamide", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Diphenhydramine HCL", "type": "DRUG" }, { "name": "Hydroxyzine HCL", "type": "DRUG" }, { "name": "Meperidine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "DIAGNOSTIC_TEST", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 224, "start_date": "2017-01-27", "completion_date": "2025-07-02", "has_results": true, "last_update_posted_date": "2026-03-09", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 2, "location_summary": "Bethesda, Maryland • New Brunswick, New Jersey", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02858310" }, { "nct_id": "NCT01391962", "title": "Sunitinib or Cediranib for Alveolar Soft Part Sarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoma, Alveolar Soft Part" ], "interventions": [ { "name": "Cediranib", "type": "DRUG" }, { "name": "Sunitinib", "type": "DRUG" }, { "name": "Prochlorperazine", "type": "OTHER" }, { "name": "Promethazine", "type": "OTHER" }, { "name": "Benzodiazepine", "type": "OTHER" }, { "name": "Filgrastim", "type": "OTHER" }, { "name": "Sargramostim", "type": "OTHER" }, { "name": "Lomotil", "type": "OTHER" }, { "name": "Loperamide", "type": "OTHER" }, { "name": "Vitamin B6", "type": "OTHER" }, { "name": "Aquaphor", "type": "OTHER" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Levothyroxine", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "16 Years to 120 Years" }, "enrollment_count": 34, "start_date": "2011-07-18", "completion_date": "2026-01-16", "has_results": true, "last_update_posted_date": "2026-02-02", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01391962" }, { "nct_id": "NCT03984045", "title": "SPG Block for Acute Pediatric Migraine", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine in Children", "Sphenopalatine Neuralgia", "Migraine in Adolescence" ], "interventions": [ { "name": "Lidocaine topical", "type": "DRUG" }, { "name": "Prochlorperazine Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Newark Beth Israel Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "10 Years to 20 Years" }, "enrollment_count": 72, "start_date": "2019-06-06", "completion_date": "2022-12-30", "has_results": false, "last_update_posted_date": "2021-11-17", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 1, "location_summary": "Newark, New Jersey", "locations": [ { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03984045" }, { "nct_id": "NCT05317000", "title": "5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Squamous Cell Carcinoma of Head and Neck" ], "interventions": [ { "name": "Combination 5-azacytidine and nivolumab", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Barbara Burtness", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2023-03-23", "completion_date": "2028-11-30", "has_results": false, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05317000" }, { "nct_id": "NCT00475085", "title": "Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nausea" ], "interventions": [ { "name": "aprepitant", "type": "DRUG" }, { "name": "dexamethasone", "type": "DRUG" }, { "name": "granisetron hydrochloride", "type": "DRUG" }, { "name": "palonosetron hydrochloride", "type": "DRUG" }, { "name": "prochlorperazine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Joseph Roscoe", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1021, "start_date": "2006-12", "completion_date": null, "has_results": true, "last_update_posted_date": "2015-11-10", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 16, "location_summary": "Mobile, Alabama • Decatur, Illinois • Wichita, Kansas + 13 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Decatur", "state": "Illinois" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Kalamazoo", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00475085" }, { "nct_id": "NCT01851369", "title": "TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Lymphomas", "Solid Tumors", "NSCLC", "Metastatic Colon Carcinoma", "Granulosa Cell Ovarian Cancer" ], "interventions": [ { "name": "TRC102", "type": "DRUG" }, { "name": "CT scan", "type": "DIAGNOSTIC_TEST" }, { "name": "Lomotil", "type": "OTHER" }, { "name": "Prochlorperazine", "type": "OTHER" }, { "name": "Metoclopramide", "type": "OTHER" }, { "name": "5-HT3 antagonist", "type": "OTHER" }, { "name": "Aprepitant", "type": "OTHER" }, { "name": "Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "OTHER", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 93, "start_date": "2013-07-12", "completion_date": "2023-08-01", "has_results": true, "last_update_posted_date": "2024-05-08", "last_synced_at": "2026-09-22T12:18:26.787Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01851369" } ] }